Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.
View Top Employees from AnokionWebsite | http://www.anokion.com |
Revenue | $10 million |
Funding | $40 million |
Employees | 36 (36 on RocketReach) |
Founded | 2010 |
Address | 50 Hampshire St, Cambridge, Massachusetts 02139, US |
Phone | +41 21 693 72 37 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Immunoengineering, Healthcare, Science and Engineering, Protein engineering, Clinical Trials, Biologics, Health Care, Autoimmune diseases, Therapeutics |
Web Rank | 19 Million |
Keywords | Immune Tolerance |
Competitors | Altus Technologies Corporation, Complix N.V., Five Prime Therapeutics, Inc., Step Pharma, Synthorx Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 621 Companies, NAICS Code 62151 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies |
Looking for a particular Anokion employee's phone or email?
The Anokion annual revenue was $10 million in 2024.
Angela Card is the Vice President, Product Development of Anokion.
36 people are employed at Anokion.
Anokion is based in Cambridge, Massachusetts.
The NAICS codes for Anokion are [621, 62151, 541, 54, 541714, 5417, 54171, 6215, 62].
The SIC codes for Anokion are [87, 873].